Steering Committee

PILOT™ Work Group:
IPF Disease Management Strategies With an Update on Clinical Trials and Ongoing Research

Objectives

• Explain the rationale for the need to research new targeted approaches to the treatment of IPF
• Discuss the latest clinical trial information and research in the area of IPF
• Review future treatment options for IPF

Paul W. Noble, MD (lead)
Yale University School of Medicine
New Haven, Connecticut

James H. Dauber, MD
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Steven D. Nathan, MD
Inova Fairfax Hospital
Falls Church, Virginia

Maria L. Padilla, MD
Mount Sinai School of Medicine
New York, New York

Steven A. Sahn, MD
Medical University of South Carolina
Charleston, South Carolina

David A. Zisman, MD
David Geffen School of Medicine at UCLA
Los Angeles, California